Ricevi le ultime notizie sulle azioni Nexalin Technology con aggiornamenti su tendenze di mercato, dati finanziari e analisi di Benzinga. Rimani informato sulle performance di NXL

Ultime notizie per

Nexalin Technology

Nexalin Technology Inc designs and develops neurostimulation products to uniquely and effectively help combat the ongoing mental health epidemic. The company has developed an easy-to-administer medical device referred to as Generation 1 or Gen-1 that utilizes bioelectronic medical technology to treat anxiety and insomnia, without the need for drugs or psychotherapy. Its original Gen-1 devices are cranial electrotherapy stimulation (CES) devices that emit waveform at 4 milliamps during treatment and are presently classified by the U.S. Food and Drug Administration (FDA) as a Class II device.

Nexalin Technology Inc

Nuix Ltd

NEXLIVING CMNTYS INC by NEXLIVING CMNTYS INC.

Nexalin Technology Inc Warrants (15/09/2025)

Press Releases

Nexalin Technology Initiates FDA Q-Submission Process for Gen-2 SYNC Following Encouraging Data and Preliminary FDA Feedback

News

Financing

Nexalin Technology Announces Pricing of $5.0 Million Public Offering of Common Stock

Nexalin Technology Announces Closing of Previously Announced $5.0 Million Underwritten Public Offering

Nexalin Technology Reconstitutes Scientific Advisory Board with Leading Experts to Advance Alzheimer's Program Amid Encouraging Data

Join Nexalin Technology's Exclusive Live Investor Webinar and Q&A Session on June 3

Nexalin Technology Appoints Highly Experienced Financial Leader Justin Van Fleet as CFO to Support Nexalin's Next Phase of Growth and Strategic Initiatives

Join Nexalin Technology's Exclusive Live Investor Webinar and Q&A Session on September 9

Nexalin Technology Announces Issuance of U.S. Patent Covering HALO™ Clarity Device Featuring DIFS™ Technology

Nexalin Technology Announces Additional Positive Clinical Results in Alzheimer's Disease with Gen-2 SYNC Neurostimulation Device

Nexalin Technology Announces Attendance at the 2025 Maxim Growth Summit

NXLIW

Adagio Medical Holdings, Inc - Common Stock

Adagio Medical Holdings

Check-Cap

Envoy Medical, Inc. - Class A Common Stock

Envoy Medical

Co-Diagnostics

electroCore

Ekso Bionics Holdings, Inc. - Common Stock

Ekso Bionics Holdings

Femasys

SeaStar Medical Holding Corporation - Common Stock

SeaStar Medical Holding

Inspira Technologies Oxy B.H.N. Ltd. - Ordinary Shares

Inspira Technologies Oxy

Iridex

Lifeward

Milestone Scientific

Modular Medical

Myomo

NeuroOne Medical Technologies Corporation - Common Stock

NeuroOne Medical Tech

Neuraxis

enVVeno Medical Corporation - Common Stock

enVVeno Medical

Profusa

Precision Optics Corporation, Inc. - Common stock

Precision Optics Corp

Vicarious Surgical Inc. Class A Common Stock

Vicarious Surgical

SINTX Technologies

Sensus Healthcare

Trinity Biotech plc - American Depositary Shares

Comments

Nexalin Technology Notizie sulle azioni

Notizie

Ultime notizie per

Le persone guardano anche

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO